Volume : 12, Issue : 06, June – 2025
Title:
FORMULATION AND EVALUATION OF FLOATING TAPENTADOL HCL TABLETS
Authors :
Mrs.T. Sowmya*, Dr.T.Mangilal, Thallam Sai Anjali, Mohammed Zaid Ul Arifeen, Nuzhath Begum, K. Shiny Avenglin, A.Shyam Prakash
Abstract :
Abstract:
The oral route is the predominant and most preferable route for drug delivery, but drug absorption is unsatisfactory and highly variable in individuals despite excellent vitro release patterns. Analgesics having similar effectiveness with improved compliance in comparison to opioids are valuable additions to the analgesic armamentarium. Polymers used in the drug delivery system are of two types Natural and Synthetic based on their origin. Both types of polymers have some advantages and disadvantages. This results in prolonged gastric retention time of floating forms which improve bioavailability of drug and improve clinical situations. FDDS is one amongst the GRDF’s used to achieve prolonged gastric residence time. From the experimental results obtained, F4 formulation has been selected as the best formulation among all the other formulations. The in vitro drug dissolution studies from the formulation were found to be controlled release. All the evaluation parameters obtained from the best formulation were found to be satisfactory. Based on the observations, prepared tablets were analysed for various parameters like weight variation, hardness, thickness, friability, swelling and floating time, In-vitro drug release, extended to 10 hours, with formulation F4 demonstrating 83.9% drug release has been seen.
Key words: Tapentadol HCL, Gastric residence time, Floating tablets, Hydrochloride.
Cite This Article:
Please cite this article in press T.Sowmya et al, Formulation And Evaluation Of Floating Tapentadol Hcl Tablets.,Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1.Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Deliv 2006; 3(2):217-33.
2.Zubedi SS, Mohammed S, Floating tablets and its polymers,Journal of Drug Delivery and Therapeutics. 2018; 8(5-s):16-24.
3.Lachman L, Lieberman HA, The theory and practice of industrial pharmacy, CBS publishers and distributors, special Indian edition, New Delhi. 2009 p. 300,301,317.
4.Vivek K. Pawar, Shaswat Kansal, Garima Garg, Rajendra Awasthi,Deepak Singodia & Giriraj T. Kulkarni (2011) Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems, Drug Delivery, 18:2, 97-110.
5.Palavi Pal, Vijaya Sharma, Lalit Singh, A review on floating type gastroretentive drug delivery system et al. IRJP2012,3(4). 9.Suresh karudumpala, Madhusudhana Chetty, Gnanaprakash K, Venkatesh B, Sankar P, A review on bilayer floating tablets, (2013) Int. J. Res. Pharma. Sci., 4(2),354-360.
6.Nikita Dixit, Floating drug delivery system, journal of current pharmaceutical research 2011;7 (1);6-20.
7.Chaturvedi Shashank, Kumari Prabha, Singh Sunil, Agrawal Vipin Kumar, approaches to increase the gastric residence time: Floating drug delivery systems-A review, Asian journal of pharmaceutical and clinical research, vol 6, issue 3, 2013, 0974-2441.
8.William E. Wade, William J. Spruill, Tapentadol hydrochloride: A centrally acting oral analgesic, Elsevier, Clinical Therapeutics,Volume 31, Issue 12, December 2009, Pages 2804-2818